We also evaluated the expression of 8 immune checkpoints of BCAM-low and BCAM-high subgroups using the TCGA database to see whether there were differences in expression level in ccRCC (Fig. 5C). This evidence concerns the gene BCAM and nonpapillary renal cell carcinoma.